Figure 10E shows the top 30 antitumor drugs with the highest relevance, among which I-BET-762 small molecule inhibitors that inhibit the function of BET (bromodomain and extra-terminal) family proteins were able to inhibit several genes related to carcinogenesis in tumor cells and immune cells, including c-Myc, pSTAT3, and pERK (18). This evidence concerns the gene MYC and neoplasm.